Skip to main content
. 2020 Mar 16;15:1809–1821. doi: 10.2147/IJN.S240436

Figure 10.

Figure 10

In vivo anti-tumor activity of MSNM@SFN+FFA in the HepG2 orthotopic tumor-bearing nude mice. HepG2 orthotopic tumor-bearing nude mice were treated with physiological saline, MSNM@SFN (40 mg/kg of SFN, oral gavage, once a day for 18 days), and MSNM@SFN+FFA (40 mg/kg of SFN, 10 mg/kg of FFA, oral gavage, once a day for 18 days). **p < 0.01 vs control treatment group.